Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avalo Therapeutics Inc (NQ: AVTX )

9.418 +0.778 (+9.01%)
Streaming Delayed Price Updated: 3:55 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avalo Therapeutics Inc

< Previous 1 2 Next >
Avalo Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Avalo Therapeutics
Via GlobeNewswire
Avalo Sells Economic Rights to Previously Out-Licensed Assets for $5 Million
From Avalo Therapeutics
Via GlobeNewswire
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 02/17/2022 -- Certain directors of Avalo Therapeutics, Inc f.k.a. Cerecor Inc are under investigation over potential breaches of fiduciary duties. 
Via SBWire
NASDAQ: AVTX Shareholder Notice: Investigation over Possible Securities Laws Violations by Avalo Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 02/04/2022 -- An investigation for investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential securities laws violations by Avalo Therapeutics, Inc. was... 
Via SBWire
Investigation for Long-Term Investors in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Announced
San Diego, CA -- (SBWIRE) -- 12/15/2021 -- Avalo Therapeutics, Inc f.k.a. Cerecor Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
NASDAQ: AVTX Investor Notice: Investigation over Potential Wrongdoing at Avalo Therapeutics, Inc f.k.a. Cerecor Inc
San Diego, CA -- (SBWIRE) -- 11/29/2021 -- An investigation on behalf of investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential wrongdoing at Avalo Therapeutics, Inc. was... 
Via SBWire
NASDAQ:AVTX Investor Notice: Investigation over Potential Securities Laws Violations by Avalo Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 11/09/2021 -- An investigation was announced for investors of Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares over potential securities laws violations by Avalo Therapeutics,... 
Via SBWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.